Suchergebnisse - "Brannath, Werner"

PubPharm (198)

1

An exhaustive ADDIS principle for online FWER control

enthalten in: Biometrical journal. Biometrische Zeitschrift | 2024

von Fischer, L. | Roig, M. | Brannath, W.

2

Discussion on "Optimal test procedures for multiple hypotheses controlling the familywise expected loss" by Willi Maurer, Frank Bretz, and Xiaolei Xun

enthalten in: Biometrics | 2023

von Brannath, W.

3

How to avoid concerns with the interpretation of two primary endpoints if significant superiority in one is sufficient for formal proof of efficacy

enthalten in: Pharmaceutical statistics | 2023

von Großhennig, A. | Thomas, N. | Brannath, W. | +1

4

Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials

enthalten in: Statistical methods in medical research | 2023

von Scharpenberg, M. | Brannath, W.

5

Effectiveness and costs of a low-threshold hearing screening programme (HörGeist) for individuals with intellectual disabilities : protocol for a screening study

enthalten in: BMJ open | 2023

von Schwarze, K. | Mathmann, P. | Schäfer, K. | +20

6

Smartphone-assisted training with education for patients with hip and/or knee osteoarthritis (SmArt-E) : study protocol for a multicentre pragmatic randomized controlled trial

enthalten in: BMC musculoskeletal disorders | 2023

von Weber, F. | Müller, C. | Bahns, C. | +19

7

The population-wise error rate for clinical trials with overlapping populations

enthalten in: Statistical methods in medical research | 2023

von Brannath, W. | Hillner, C. | Rohmeyer, K.

8

Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials

enthalten in: Statistical methods in medical research | 2023

von Scharpenberg, M. | Brannath, W.

9

How to avoid concerns with the interpretation of two primary endpoints if significant superiority in one is sufficient for formal proof of efficacy

enthalten in: Pharmaceutical statistics | September/Oktober 2023

von Großhennig, A. | Thomas, H. | Brannath, W. | +1

10

How to avoid concerns with the interpretation of two primary endpoints if significant superiority in one is sufficient for formal proof of efficacy

enthalten in: Pharmaceutical Statistics | 2023

von Großhennig, A. | Thomas, N. | Brannath, W. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]